Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
49,180,519
-
Shares change
-
+1,344,896
-
Total reported value, excl. options
-
$1,786,666,273
-
Value change
-
+$50,908,665
-
Put/Call ratio
-
540%
-
Number of buys
-
58
-
Number of sells
-
-64
-
Price
-
$36.33
Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2025
161 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q3 2025.
Immunocore Holdings plc - Ordinary shares (IMCR) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,180,519 shares
of 49,942,911 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (7,063,896 shares), RTW INVESTMENTS, LP (4,869,798 shares), WELLINGTON MANAGEMENT GROUP LLP (4,780,889 shares), FMR LLC (4,420,403 shares), PRIMECAP MANAGEMENT CO/CA/ (3,754,560 shares), Bellevue Group AG (2,796,803 shares), BAKER BROS. ADVISORS LP (2,322,656 shares), TANG CAPITAL MANAGEMENT LLC (2,305,608 shares), Deep Track Capital, LP (1,800,000 shares), and BVF INC/IL (1,574,288 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.